Lataa...
Efficacy and safety of tiotropium Respimat(®) SMI in COPD in two 1-year randomized studies
Two 1-year studies evaluated the long-term efficacy and safety of tiotropium 5 or 10 μg versus placebo, inhaled via the Respimat(®) Soft Mist™ Inhaler (SMI). The two studies were combined and had 4 co-primary endpoints (trough FEV(1) response, Mahler Transition Dyspnea Index [TDI] and St George’s Re...
Tallennettuna:
| Päätekijät: | , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2921687/ https://ncbi.nlm.nih.gov/pubmed/20714373 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|